Skip to main content

Table 3 Secondary outcomes stratified by under 5 years of age and over 5 years of age

From: In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia

Outcome ≤5 years of age >5 years of age Total
Fever*, n/N (%)    
   Day 1 9/23 (39.1) 32/95 (33.7) 41/118 (34.8)
   Day 2 1/22 (4.6) 10/94 (10.6) 11/116 (9.5)
   Day 3 0/21 (0) 8/94 (8.5) 8/115 (7.0)
Parasitaemia, n/N (%)    
   Day 2 5/22 (22.7) 3/94 (3.2) 8/116 (6.9)
   Day 3 1/21 (4.8) 0/94 (0) 1/115 (0.9)
Gametocytaemia, n/N (%)    
   Day 2 6/22 (27.3) 8/94 (8.5) 14/116 (12.1)
   Day 3 1/21 (4.8) 5/94 (5.3) 6/115 (5.2)
   Day 7 0 4/94 (4.3) 4/115 (3.5)
   Day 14 0 1/94 (1.1) 1/115 (0.9)
Mean Haemoglobin g/dL, mean (SD)    
   Day 28 12.0 (1.2) 13.7 (1.8) 13.4 (1.8)
   Day 42 12.0 (1.1) 13.8 (1.8) 13.5 (1.8)
Mean Difference in Haemoglobin Day 0 to 42 g/dL, (SD) 1.9 (1.9) 0.7 (2.1) 0.9 (2.1)
  1. *Subjective fever or axillary temperature ≥37.5°C